Spontaneous bacterial peritonitis norfloxacin

Runyon BA, Borzio M, Young S, Squier SU, Guarner C, Runyon MA Effect of selective intestinal decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 1995,21 1719-1724. 

Eosinophilia occurred in a 35-year-old man with alcoholic cirrhosis taking norfloxacin 400 mg bd for prophylaxis of spontaneous bacterial peritonitis (5). 

Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis Results of a double-blind, placebo-controlled trial. Hepatology 1990 12 716-724. 

Dupeyron C, Mangeney N, Sedrati L, et al. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother 1994 38 340-344. 

Novella M, Sola R, Soriano G, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997 25 532-536. 

---